Fig. 5From: Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancerCumulative incidence of radiation pneumonitis of grade 2 or more stratified by lung V40. The dichotomizing value was based on ROC analysis. Lung V40: percentage of lung volume exceeding 40Â GyBack to article page